About
Joshua Funder joined GBS Partners in 2004 and has more than 17 years of experience in biotechnology research, management and venture investing. Joshua has experience as founder, director and chairman of biotechnology companies in Australia and the US, and brings extensive experience of international venture syndication. Joshua served as interim CEO of Proacta Inc. following GBS investment and is on the board of directors of GBS portfolio companies Spinifex Pharmaceuticals Pty Ltd, Pathway Therapeutics Inc. and Celladon Corp. Joshua previously was director of GBS investment company Peplin Inc., which won the AVCAL award for the best early stage investment in 2010. Before joining GBS, Joshua worked in corporate strategy and development at Infinity Pharmaceuticals in Boston and the Boston Consulting Group in San Francisco. In addition he worked with the Clinton Foundation HIV/AIDS Initiative to successfully negotiate reduced prices for anti-retrovirals and initiate pharmaceutical su
Position in the VCSift Database
- • 110 investors hold the Member of the Board of Directors role in VCSift. Joshua Funder is one of them.
- • 705 investors are based in Melbourne, Victoria, Australia.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Melbourne, Australia
Contact Information
Find more investors like Joshua
Search Investors